Curran Terrie Insider Profile

4 Followers
Curran Terrie, PRES., GLBL INFLAM. AND IMMUN. at Celgene, holds 5.24K shares in Celgene (Ticker: CELG), holds ― shares in Myovant Sciences (Ticker: MYOV), holds ― shares in Phathom Pharmaceuticals (Ticker: PHAT).
tipranks
Curran Terrie

Curran Terrie
Celgene (CELG)
PRES., GLBL INFLAM. AND IMMUN.

Not Ranked
Curran Terrie has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Curran Terrie does not currently own shares as a corporate insider.
A breakdown of Curran Terrie's holdings

Insider Roles

Myovant Sciences
(MYOV)
Director
Phathom Pharmaceuticals
(PHAT)
President and Chief Executive, Director
Arcutis Biotherapeutics
(ARQT)
Director
Roles that Curran Terrie holds in companies

Most Profitable Insider Trade

Stock:
Celgene
(CELG)
Rating:Informative Sell
Date:Sep 19, 2019 - Sep 19, 2020
Return:-9.30%
The most profitable trade made by Curran Terrie

Curran Terrie's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CELG
Celgene
Nov 22, 2019
Uninformative Buy
$567.07K
Myovant Sciences
Director
Phathom Pharmaceuticals
President and Chief Executive, Director
Arcutis Biotherapeutics
Director
List of latest transactions for each holding click on a transaction to see Curran Terrie's performance on stock

Curran Terrie insider profile FAQ

What is the percentage of profitable transactions made by Curran Terrie?
The percentage of profitable transactions made by Curran Terrie is ―.
    What is the average return per transaction made by Curran Terrie?
    The average return per transaction made by Curran Terrie is ―.
      What stocks does Curran Terrie hold?
      Curran Terrie holds: CELG, MYOV, PHAT, ARQT stocks.
        What was Curran Terrie’s latest transaction?
        Curran Terrie latest transaction was an Uninformative Buy of ―.
          What was Curran Terrie's most profitable transaction?
          Curran Terrie’s most profitable transaction was an Informative Sell of CELG stock on September 19, 2019. The return on the trade was -9.30%.
            What is Curran Terrie's role in Celgene?
            Curran Terrie's role in Celgene is PRES., GLBL INFLAM. AND IMMUN..
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.